Results 31 to 40 of about 1,272,372 (129)

Breast cancer in Malta : a comparative study between the year 2000 and 2010 [PDF]

open access: yes, 2013
Introduction: During the last decade, Malta experienced the introduction of a number of programmes and initiatives aiming to raise risk and cancer awareness on breast cancer.
Caruana, Mandy, Caruana Dingli, Gordon
core  

The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer. [PDF]

open access: yes, 2011
Summary In this study, we analyzed vitamin D receptor (VDR) expression and survival in a breast cancer patient cohort of 82 breast cancer patients. Immunohistochemical analysis was possible in 91.5% of the patients (75/82). Staining was evaluated using
Lenhard, Miriam   +17 more
core   +1 more source

Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma

open access: yes, 2021
Squamous cell carcinoma of the breast and its subtype, basal-human epidermal growth factor receptor 2 (HER2) phenotype, are very rare. Herein, we report a patient who developed recurrence of squamous cell carcinoma of the breast with basal-HER2 subtype 6
임우성   +7 more
core   +1 more source

Olive Oil Polyphenols: A Promising Approach for Cancer Prevention and Therapy

open access: yesFood Science &Nutrition, Volume 13, Issue 9, September 2025.
The manuscript explores the anticancer potential of olive oil polyphenols, specifically hydroxytyrosol and oleuropein, which exhibit potent antioxidant, anti‐inflammatory, and anticancer properties. These bioactive compounds modulate key molecular pathways involved in the initiation and metastasis of cancer. They induce apoptosis, inhibit angiogenesis,
Muhammad Junaid Anwar   +15 more
wiley   +1 more source

Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy

open access: yesAdvanced Therapeutics, Volume 8, Issue 2, February 2025.
The extracellular matrix (ECM) is pivotal in cancer progression, influencing tumor growth, metastasis, and therapy resistance. This paper explores ECM remodeling, highlighting components like collagens and proteoglycans, their impact on immune evasion, and emerging therapies targeting ECM mechanics and composition.
Nimeet Desai   +8 more
wiley   +1 more source

A study of the molecular pathology of ductal carcinoma in situ and invasive ductal carcinoma of the breast. [PDF]

open access: yes, 2005
The biological validity of the histopathological classification of ductal carcinoma in situ (DCIS) of the breast was evaluated in this study by correlating the three histopathological grades of DCIS to immunohistochemical expression of Ki67, p53, cerbB-2,
Rehman, S.
core  

Enhanced expression of galectin‐9 in triple negative breast cancer cells following radiotherapy: Implications for targeted therapy

open access: yesInternational Journal of Cancer, Volume 156, Issue 1, Page 229-242, 1 January 2025.
What's new? Immune checkpoint inhibitors have radically advanced cancer treatment. Frequently, immune checkpoint inhibitors are combined with radiation, but radiation therapy may spur the development of treatment resistance. Here, the authors show that in triple‐negative breast cancer (TNBC), expression of the immune checkpoint galectin‐9 (Gal‐9) is ...
Cédric Lerévérend   +24 more
wiley   +1 more source

Expression of shelterin and shelterin-associated genes in breast cancer cell lines [PDF]

open access: yes, 2014
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University.Mammalian telomeric DNA consists of tandem repeats of the sequence TTAGGG associated with a specialized set of proteins, known collectively as Shelterin ...
Motevalli, Azadeh
core   +5 more sources

Fibrosis‐Encapsulated Tumoroid, A Solid Cancer Assembloid Model for Cancer Research and Drug Screening

open access: yesAdvanced Healthcare Materials, Volume 13, Issue 31, December 16, 2024.
The Multi‐Layer Spheroid (MLS) formation method can construct Fibrosis‐Encapsulated Tumoroids (FETs), which replicate the structural characteristics of peritumoral fibrosis, serving as a tissue‐level simulator for cancer research and drug evaluation in solid tumors.
Yeonsue Jang   +5 more
wiley   +1 more source

Targeted Cancer Therapy‐on‐A‐Chip

open access: yesAdvanced Healthcare Materials, Volume 13, Issue 29, November 22, 2024.
Targeted cancer therapy (TCT) minimizes side effects by specifically treating tumor cells. Traditionally tested with 2D cell cultures and animal studies, TCT now utilizes cancer‐on‐a‐chip (CoC) platforms for in vitro testing. This review examines CoCs in developing and testing TCTs, identifying biomarkers, and evaluating both free and encapsulated TCTs,
Heba Abed   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy